Apable, Rinavie .
HRN: 26-43-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2025
CEFUROXIME 1.5GM (VIAL)
04/11/2025
04/12/2025
IV
1.5g
Q8
Post Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes